Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Arrivo BioVentures

Arrivo BioVentures
2015 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Early Stage VC LATEST DEAL TYPE
$49M LATEST DEAL AMOUNT
3 INVESTORS
Description

Developer of reformulated biopharmaceutical drugs designed to focus on accelerating biologics and small molecules through clinical development. The company's reformulated biopharmaceutical drugs are produced after identifing regulatory strategies to expedite the path to approval through efficient clinical programs, enabling doctors to improve patient lives.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Other Pharmaceuticals and Biotechnology
Primary Office
  • Aerial Center Executive Park, 9001 Aerial Center Parkway
  • Suite 110
  • Morrisville, NC 27560
  • United States

+1 (919) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Arrivo BioVentures’s full profile, request a free trial.

Arrivo BioVentures Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 25-May-2016 $49M 0000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Arrivo BioVentures Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Azur Pharma Corporation Minority 000 0000 000000 0
Rex Health Ventures Corporate Venture Capital Minority 000 0000 000000 0
Solas BioVentures Venture Capital Minority 000 0000 000000 0

Arrivo BioVentures Executive Team (6)

Name Title Board
Seat
Contact
Info
Stephen Butts Co-Founder, Chief Executive Officer & Manager
Michael Ackermann Ph.D Co-Founder, Manager and Chief Business Officer
Jed Black MD Co-Founder & Scientific Advisor
William Wofford JD Co-founder, Manager, General Counsel and Head of Corporate Development
Greg Rigdon Ph.D Vice President of Scientific Affairs
You’re viewing 5 of 6 executives. Get the full list »